High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery

医学 射血分数 经皮冠状动脉介入治疗 经皮 心脏病学 内科学 心理干预 语句(逻辑) 心肌梗塞 心力衰竭 政治学 精神科 法学
作者
Andreas Schäfer,Mirvat Alasnag,Daniele Giacoppo,Carlos Collet,Tanja K. Rudolph,Ariel Roguin,Piotr Buszman,Róisín Colleran,Giulio Stefanini,Thierry Lefèvre,Nicolas M. Van Mieghem,Guillaume Cayla,Christoph Naber,Andreas Baumbach,Adam Witkowski,Francesco Burzotta,Davide Capodanno,Dariusz Dudek,Rasha Al-Lameé,Adrian Banning
出处
期刊:Eurointervention [European Association of Percutaneous Cardiovascular Interventions]
卷期号:21 (1): 22-34 被引量:2
标识
DOI:10.4244/eij-d-23-01100
摘要

This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to define procedural and contemporary technical requirements that may improve the efficacy and safety of percutaneous coronary intervention (PCI), both in the acute phase and at long-term follow-up, in a high-risk cohort of patients on optimal medical therapy when clinical and anatomical high-risk criteria are present that entail unacceptable surgical risks, precluding the feasibility of coronary artery bypass grafting (CABG). This document pertains to patients with surgical contraindication according to the Heart Team, in whom medical therapy has failed (e.g., residual symptoms), and for whom the Heart Team estimates that revascularisation may have a prognostic benefit (e.g., left main, last remaining vessel, multivessel disease with large areas of ischaemia); however, there is a lack of data regarding the size of this patient population. This document aims to guide interventional cardiologists on how to proceed with PCI in such high-risk patients with reduced left ventricular ejection fraction after the decision of the Heart Team is made that CABG - which overall is the guideline-recommended option for revascularisation in these patients - is not an option and that PCI may be beneficial for the patient. Importantly, when a high-risk PCI is planned, a multidisciplinary decision by interventional cardiologists, cardiac surgeons, anaesthetists and non-invasive physicians with expertise in heart failure management and intensive care should be agreed upon after careful consideration of the possible undesirable consequences of PCI, including futility, similar to the approach for structural interventions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
盐冰应助王博林采纳,获得10
1秒前
2秒前
听雨完成签到,获得积分10
3秒前
3秒前
桐桐应助科研通管家采纳,获得10
4秒前
JamesPei应助科研通管家采纳,获得10
4秒前
CodeCraft应助科研通管家采纳,获得10
4秒前
汉堡包应助科研通管家采纳,获得10
4秒前
充电宝应助科研通管家采纳,获得10
4秒前
乐乐应助科研通管家采纳,获得30
4秒前
SciGPT应助科研通管家采纳,获得10
4秒前
果酱的奥特曼完成签到,获得积分10
4秒前
SciGPT应助科研通管家采纳,获得20
4秒前
华仔应助科研通管家采纳,获得10
4秒前
今后应助科研通管家采纳,获得10
4秒前
zho应助科研通管家采纳,获得10
4秒前
李爱国应助科研通管家采纳,获得10
4秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
在水一方应助科研通管家采纳,获得10
5秒前
5秒前
Akim应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
称心文博完成签到,获得积分20
6秒前
6秒前
风趣的洙发布了新的文献求助10
6秒前
7秒前
称心文博发布了新的文献求助30
11秒前
12秒前
厚朴1214发布了新的文献求助10
12秒前
善学以致用应助臧晓蕾采纳,获得10
12秒前
15秒前
15秒前
魏伯安发布了新的文献求助10
18秒前
暴躁壮壮完成签到 ,获得积分10
19秒前
Gzq发布了新的文献求助10
20秒前
21秒前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Robot-supported joining of reinforcement textiles with one-sided sewing heads 800
水稻光合CO2浓缩机制的创建及其作用研究 500
Logical form: From GB to Minimalism 500
2025-2030年中国消毒剂行业市场分析及发展前景预测报告 500
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III – Liver, Biliary Tract, and Pancreas, 3rd Edition 400
Elliptical Fiber Waveguides 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4170548
求助须知:如何正确求助?哪些是违规求助? 3706244
关于积分的说明 11694237
捐赠科研通 3392235
什么是DOI,文献DOI怎么找? 1860610
邀请新用户注册赠送积分活动 920451
科研通“疑难数据库(出版商)”最低求助积分说明 832674